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TECHNICAL NOTE
Assessing the peritoneal dialysis capacities of individual patients
BöRJE HARALDSSON
Departments of Nephrology and Physiology, University of Goteborg Gotebo, Sweden
Assessing the peritoneal dialysis capacities of individual patients. A
method for measuring the peritoneal dialysis capacity (PDC) of the
individual patient has been developed as an aid to treatment of patients
with renal failure and peritoneal dialysis. The patient collects the data him
or herself during an almost normal CAPD day using a carefully designed
protocol whereby the nursing time is kept to a minimum. The three-pore
model is used to describe the PDC with three physiological parameters:
(1.) the 'Aiea' parameter (Ajx), which determines the diffusion of small
solutes and the hydraulic conductance of the membrane (LS); (2.) the
final reabsorption rate of fluid from the abdominal cavity to blood (JvAR)
when the glucose gradient has dissipated; and (3.) the large pore fluid flux
(of plasma, JvL), which determines the loss of protein to the PD fluid. In
the adult PD population (age 60, N = 97) the normal 'Area' parameter
was 23,600 cm/1.73 m2, with an SEM of 650. The JVAR was 1.49 ml/min/1.73
m2 and JvL was 0.078 ml/min/1.73 m2. The PDC parameters were
reproducible and could adequately predict the concentrations of the test
sQiutes as well as that of 132-microglobulin. The results in terms of
clearance, 'UF volume' and nutritional consequences were presented on
easily understandable graphs, whereby patient compliance was improved,
These physiological parameters are highly dynamic, as evidenced by the
marked increases observed during peritonitis. It seems safe to conclude
that PDC is a useful tool to achieve adequate dialysis and to enhance the
understanding of PD exchange.
Peritoneal dialysis (PD) is an increasingly popular life-support-
ing therapy for patients with chronic renal failure. In contrast to
the membranes used in hemodialysis, the functional characteris-
tics of the individual PD membrane are unknown. indeed, it was
recognized early that there are large differences in solute and fluid
exchange between individual patients treated with continuous
ambulatory peritoneal dialysis (CAPD) [1]. Moreover, the conse-
quences of inadequate, or rather insufficient, dialysis appear
gradually over a long period of time and include the reappearing
uremic symptoms as well as increased morbidity and mortality.
The effects appear in patients as the residual renal function
declines, a phenomenon often denoted "the end of the honey-
moon period." Previously, infections were the major complica-
tions of PD. However, the risk of peritonitis has been reduced in
the last few years and other problems such as underdialysis are
now evident. Against this background, it is not surprising that
there is growing interest in methods of measuring PD exchange
and providing adequate dialysis.
In 1987, Twardowski et al introduced a simple peritoneal
equilibration test (PET) which greatly improved our knowledge of
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the individual patients and what dialysis treatment to use [2, 3}.
Due to the variability of the PET, it has been suggested that
predictions should be based on four to five exchanges [4]. In order
to reduce the variability, the patient can roll from side to side to
achieve better mixing of PD fluid [2, 3]. It is evident, however, that
this procedure creates an artificial situation different from the
ordinary CAPD day. The exchange is most probably affected by
shaking, as has been seen in rats [5, 6], and the procedure has
been criticized [4]. There are also reports of exceptionally low
variability of PET in selected patients [7]. No doubt, PET can be
used to select patients more suitable for automated peritoneal
dialysis (APD, the so-called high transporters), or to ktentifr low
transporters less suitable for PD Another, perhaps better, way to
improve PET is the APEX, where the APEX time is the point
where the concentrations of glucose (CD/CDO dialysate concen-
tration at time t over initial dialysate concentration) and urea
(CD/CP = dialysate over plasma concentration ratio) cross [8].
Albeit attractive in their simplicity, the semiquantitative nature of
PET and APEX cannot give any details of the physiological
properties of the PD membrane. Moreover, whereas some au-
thors find PET to be of clinical value [7, 9], others have reported
that PET is incapable of predicting PD exchange [10]. Naturally,
the latter objection is also valid for more sophisticated predictions
based on PET data [11].
How much is adequate dialysis? This pertinent question is not
easily answered. There are guidelines that recommend a weekly
Kt/V (= clearance multiplied with time over distribution volume)
for urea of 1.7 and a weekly creatinine clearance of 50 liter/week
[12] or 55 liter/week [13]. Indeed, clinical studies have suggested
that weekly creatinine clearance, creatinine Kt/V or urea Kt/V are
useful to assess the effectiveness of PD in the individual patient
[14, 151. Some authors have found statistical correlation to one
parameter only [16, 17]. On the other hand, there are studies
suggesting that there is a poor correlation between urea kinetic
indices and the clinical outcome in CAPD patients [18]. One
major problem is to design studies that fully take into account the
comorbid conditions since these may confound the analysis. At
present, it seems safe to conclude that there is a need for a good
noninvasive technique to measure the transperitoneal passage of
fluid and solutes under normal PD conditions.
In a previous study, transport was simulated during PD using a
small computer to illustrate the importance of various factors in
the three-pore model [19]. In the present paper, the peritoneal
dialysis membrane characteristics (PDC) of individual patients
were assessed using a structured test protocol and a computer
program to improve our understanding of PD and to ensure
adequate dialysis.
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Methods
Theoretical background of the three-pore model
Ernest Starling [20] studied the peritoneum one century ago
when he formulated the forces behind the transcapillary passage
of fluid, and this so-called "Starling balance" seems to be univer-
sal for all microvascular beds. Landis and Pappenheimer extended
our knowledge of the transcapillary exchange of fluid and solutes
and introduced the pore concept using elegant, carefully designed
studies [21]. A second pore population (large pores or "leaks"
with a radius of 25 nm) was postulated by Grotte [221 based on
studies on the lymph composition of dextran fractions with
different molecular weights. Moreover, Yudilevich and Alvarez
[231 presented evidence for a third water-exclusive pathway in dog
hearts in 1967. Thus, the components of the modern "three-pore"
theory were already known 25 years ago. More recently, Rippe
and Haraldsson [24] showed that the transport of solutes and
water across heteroporous membranes could be expressed in
explicit terms using irreversible thermodynamics and nonlinear
flux equations. indeed, almost all vascular beds seem to be
heteroporous [25, 26]. In addition, proteins have been identified
as water-exclusive channels in different cell membranes, for
example, CHIP 28 [27].
In a series of articles, Rippe and coworkers have introduced
modern theories of capillary physiology to the field of peritoneal
dialysis. The three-pore model of fluid and solute transport (or
"two-pore" model of solute transport) across the peritoneal
membrane has been documented in a series of articles [19,
28—30]. According to this model, the PD membrane can be
regarded as a (capillary) membrane with three equivalent (func-
tional) pore populations. The small pore with a Stokes-Einstein
radius around 4.7 nm represents the major pathway for small
solutes. Macromolecules are transported by convection through a
few large pores, SE radius 25 nm. Finally, a third water-exclusive
cell pathway is present through which almost 40% of the water
passes during an average PD dwell with glucose as osmotic agent.
The large pores account for 5% of the hydraulic conductance
(L,S, or UF coefficient), the cell pores 1% of LS while more than
90% of LS is due to the small pores. The apparent contradiction
of the latter two sentences are due to the fact that glucose exerts
100% of its osmotic force across the cell pore pathway and only a
few percent across the small pore equivalent.
Patient selection
All patients treated with CAPD at the Department of Ncphrol-
ogy, Sahlgrenska Hospital, Goteborg, Sweden from May 1991
were invited to use the PDC test in order to ascertain adequacy of
dialysis and gain insight into the physiological properties of their
PD membrane. The test was done at home by the patient in the
majority of cases. Apart from their renal insufficiency the patients
were healthy, except those patients who were included in the
peritonitis group (see below). The study was approved by the
ethical committee of the University of Goteborg.
The protocol for PDC determinations
The test was designed to: (i) mimic the ordinary CAPD day, (ii)
be performed by the patient with a minimum of nursing time; (iii)
yield data from different dwell times and glucose strengths; and
(iv) allow calculations of mass balance during a 24 hour period.
Table 1. A representative PDC determination on a male patient
Glucose Volume of
cone PD fluid
giliter ml
Time of Time of Drain
start of start of '0me ml
fill drain Meas Cale
PD samples 15 2010 10.16 pm 7.53 am 2060 2024
15 2010 8.10 am 10.24 am 2086 2132
23 2008 10.56 am 3.04 pm 2518 243K
15 2012 4.l3pm 7.3Opm 2022 2179
23 2015 7.55 pm 10.05 pm 2538 2308
15 1994 10.32 pm 7.57 am 1999 2073
Urea Creat Glucose Albumin
cone mM cone LM cone mM cone gluier
Meas Calc Meas Calc Meas CaIc Mess Calc
30 31.8 762 782 19.1 18.4 0.46 0.49
26 24.5 511 524 41.0 45.8 0.21 0.17
29 28.9 596 657 44.4 41.8 0.26 0.30
28 27.9 562 613 37.0 38.0 0.24 0.21
26 24.1 479 500 52.5 62.9 0.16 0.20
30 31.7 733 776 18.1 19.2 0.49 0.43
Sodium Urea
Blood samples
Creatinine Glucose
albumin
mM gluier
12 Mar 8.02 am 135 31 792 12.7 17
13 Mar 7.40 am 133 33 794 12.7 17
24-hr urine Cone of Cone of
volume urea creatinine
ml mM M
Urine samples 135 2.1 7800
The male patient (E.K.), age 62, was diagnosed with diabetes mellitus
type I since childhood. He has a height of 160cm and wepht of 64kg, thus
his body surface area of 1.70 m2 and a BMI of 25 kg/rn
The patient performed the PDC test himself during an "al-
most" normal CAPD day following a protocol with five exchanges
per 24 hours. The previous overnight dwell was weighed and
sampled after mixing (= zero sample). The 'PDC-day' started
with a short (2 to 3 hr) PD dwell followed by two intermediate
dwells (4 to 6 hr), another short exchange, and finally an overnight
dwell (10 to 12 hr). Two different glucose concentrations were
alternately used. The well-mixed dialysate samples (50 to 100 ml)
and two blood samples (with a 24 hr interval) were analyzed with
respect to the concentration of urea, creatinine, glucose, albumin
and sodium (in blood only). The exact time of starting each
dialysate drain and of starting each fill with fresh fluids was noted,
along with the weights of the bags with new or used dialysis fluid.
Minimal flushing was used. A 24-hour urine collection was made,
the volume measured and the concentrations of urea, creatinine
and albumin determined. An example of the PDC protocol is
shown in Table 1. Finally, the results of analysis of the blood,
dialysate and urine samples together with the protocol data were
entered into a computer and the PDC parameters calculated
(Table 2).
Laboratory analyses
All dialysate samples were taken by the patient, kept cool (8°C)
if possible, and delivered when the second blood sample was
taken, that is, within 24 hours. Analyses were performed as
routine procedures at the hospital's central laboratoiy The
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clearance
Solute
Molecular
wt
Stokes-Einstein
radius nm
mi/mini
1.73 m2
Urea 60.6 0.26 6.4
Creatinine 113 0.30 6.1
Vitamin B12 1355 0.84 2.9
/32-microglobulin 9100 1.62 1.0
Albumin 69000 3.55 0.2
concenttation of creatinine (Cr) was automatically corrected for
the amount of glucose in the samples
[rki.r = [Cr] — 0.35 [Glue]
where the factor (0.35) was dependent on the analytical procedure
of the laboratory. The concentration of creatinine is in mol/1iter
and glucose mmol/liter.
Calculations of the PDC parameters
The three PDC parameters are:
(1.) The area parameter. The unrestricted pore area available for
exchange over the difihision distance (A0/x) defines the area
parameter. The magnitude of the area parameter is dependent on
the assumptions of the present three-pore model (Discussion).
(2.) The absoiption. The absorption is the final reabsorption
rate of fluid from the abdominal cavity to blood (JvAR). The
absorption is rather independent of the theoretical model used,
since it reflects the last phase of the drain volume versus time
curve (for details see Appendix Eq. 16).
(3.) The large pore flow. The large pore flow is the flux of plasma
through the large pores (JYL) and is a parameter unique to the
three-pore model. Only the larger plasma proteins are subjected
to any significant sieving across the large pores. does not
influence the transport of small solutes or fluid. The JVL is quite
independent of the assumptions in the model since it is given by
the actual 'loss' of plasma proteins (see Appendix Eq. 13 for
details).
The three PDC parameters are obtained as the best fit between
theory and experimental data using non-linear regression and
iterative calculations of the three-pore equations of transcapillary
exchange analysis [31]. The diffusive capacity of any given solute
can be predicted based on its molecular size and the A0/.x, (Eq.
6). The hydraulic conductance (LS) is calculated from A0/&, and
there is an uncoupling of LS from A0/z.x only if the calculated UF
volume deviates more than 10% from that measured, (Eq. 7). The
water-exclusive (cell) pathway is assumed to have a constant
fraction of LS (f = 1.0%), while the large pore fraction of LS
is obtained from the PDC parameter JVL and Equation 13.
Moreover, the small and large pore radii are assumed to be
constant (4.7 and 25 nm, respectively), assumptions that seem
valid [25, 321. In addition, the hydrostatic pressures in the
capillaries (Pcapjii = 15 mm Hg) and intraperitoneally (P1 = 6mm
Hg) are constant (Discussion).
The PD exchange is less effective during the phases of fluid fill
and drain due to the smaller i.p. volumes. This effect is accounted
for in the analysis by calculating the time of dialysis from the start
of the fill to the start of drain. The residual intraperitoneal volume
is considered to be 250 ml for a patient weight of 70 kg, and scaled
to the individual patient weight (Appendix). The changes of i.p.
fluid volume and solute concentration with time are also shown in
the Appendix. These calculations are repeated for each solute, for
every second minute (for the first hour) then every tenth minute
during the dwell time and for all exchanges during the day. After
adjustment of the PDC parameters, the procedure is repeated
another 3 to 10 times until the "best fit" between experimental
and calculated data is obtained. If the calculated UF volume is
different from the measured UF volume, there is uncoupling of
the LS (= UF coefficient) from the area parameter (Eq. 7). The
Table 2. Results of the PDC calculations for the patient in Table 1
1. Residual renal function
Urea clearance
Creatinine clearance
RRF = GFR
Proteinuria
2. PDC parameters
Unrestricted area (A01)
Final absorption rate (JvAR)
Large pore fluid flux (JvL)
1
>(2C
a-
U-
025 ml/min/l.73 m2
0.90 ml/min/1.73 m2
0.60 ml/min/1.73 m2
0.3 g/24 hr
33,600 cm/1.73 m2
1.31 ml/min/1.73 m2
0.11 ml/min/1.73 m2
1)10 mI/mm/mm Hg/1.73 m2
0.44 ml/min/1.73 m2
15mm Hg
17.5 mm Hg
12%
3. Other parameters calculated
Hydraulic conductance (LS)
Estimated lymph flow
Hydrostatic capillary pressure
Oncotic pressure
Large pore fraction of LS
4. Calculated PD clearance with a PD regime of 4 >< 2 liters of 23
g/liter of glucose
0 20 40 60 80 100
Age
Fig. 1. The age distribution in the PDC population.
Weekly urea Kt/V (PD + urine) 1.88
Total clearance for a solute the 6.7 mi/rn in/1.73/m2
size of creatinine
Estimated daily fluid removal 1900 ml
Nutritional effects of a PD regime of 4 x 2 liters of 23 g/liter of glucose
Uptake of glucose from PD
Caloric requirements
PD loss of proteins
Protein requirements
UGR
CGR
PNA
Calculated LBM
LBMJW
510 kcal/day
1600 kcal/day
7.7 g/day
59 g/day
408 mmol/24 h
7.66 mmol/24 h
2.08 g/kg/day
32.5 kg
51%
The uverage time of drain was 34 mm. Abbreviations are in the
Appendix.
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calculation procedure takes approximately four seconds with an
average 486DX processor.
PDC during peritonitis
A PDC test was performed on patients who were admitted into
the hospital for episodes of peritonitis. Measurements were made
during one of the first two days, using the protocol given above.
Results
General
The PDC measurements were performed by 97 stable adult
uremic patients treated with peritoneal dialysis, mainly CAPD.
The average age was 60 1 years (range 20 to 85; Fig. 1). All
patients were able to follow the protocol. The underlying disease
of the uremic condition showed the panorama that is common in
a dialysis population.
Accuracy of the PDC calculations
A representative example of a PDC measurement is given in
Figure 2, expressed as measured data plotted against calculated
values (all expressed in percent of the maximal measured value)
for drain volume and the concentrations of urea, creatinine,
glucose and albumin. Table 1 shows the data from another patient
together with the calculated parameters.
In Figure 3 data from all 97 patients are presented as mean
calculated (y) versus measured (x) data for drain volume and the
concentrations of urea, creatinine, glucose and albumin. Linear
regression gives for drain volumes: y = 0.99x — 60, r2 = 0.99,N = 97;
for urea concentrations: y = 1.02x — 0.55, r = 0.96, N = 97; for
creatinine concentrations: y = 0.99x + 39, r = 0.97, N = 97;
for glucose concentrations: y = 0.99x + 6.1, r2 0.80, N =
97; and, finally, for albumin: y = 0.83x + 0.12, r2 = 0.88, N = 97.
The sixth panel describes /32-microglobulin as calculated using the
measured f32-microglobulin concentration values in the regression
analysis versus not using these measured data: y = 1.25x + 0.10,
= 0.73. It is evident from the latter 358 measurements that
there was a high variability in the data and that actually measuring
80
40
0
Fig. 2. A representative esample of a PDC
measurement in a female CAPD patient, age 66
with interstitial nephritis. Calculated values are
plotted against measured values and the data
are expressed in percent of the maximum
.U measured concentration of each solute: urea
(S), creatinine (0), glucose (x), albumin (+),
or drain volume (•).
Fig. 3. Measured (x) against calculated (y) values for drain volumes (ml, A),
creatinine concentration (psi, B), glucose (mAt, C), urea (mM, D), albumin
(giliter, E). The mean values are shown for 97 patients. F describes the
concentration of /32-microglobulin (mg/liter) calculated using measured
data of this solute against estimations made without using the measured
132-microglobulin values.
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20 304050
Area, A0i2,,ix 1000 cm/i. 7 m2
Fig. 4. The unrestricted pore area over diffusion distance, A0Ix, in a
population of 97 patients treated with peritoneal dialysis.
the f32-microglobulin concentration did not improve the analysis
to any significant degree.
Distribution of the PDC parameters
(1.) The area parameter or the unrestricted pore area over
diffusion distance, A1)/zx, had a mean value of 23,590 cm/1.73 m2
with an SEM of 653 (N = 97, range 8,012 to 47,475) and a
distribution as shown in Figure 4. The highest A0/& (47,475
cmIl.73 m2) was found in a patient with secondary amyloidosis
due to ankylosing spondilitis with no signs of peritonitis. He did,
however, have active arthritis and two other measurements within
18 months showed similar values (51,780 and 51,120). The lowest
value was obtained in a man (age 42) with chronic glomerulone-
phritis and no history of intraabdominal infections or previous PD
episodes; again, repeated measurements a few months later gave
similar results (8,880 and 8,770).
The mean (23,600) 1 SD (6,400) data give an opportunity to
compare the area parameter to the PET nomenclature. Thus, a
patient with a large area parameter (AcJLS.X >30,000) would be
denoted a 'high transporter' according to PET, 23,600 to 30,000
would be 'high average', 17,200 to 23,600 would be 'low average',
and a small Area parameter (A0/.x <17,200) would be a 'low
transporter' (Table 3).(2.) The final reabsorption rate of fluid from the abdominal
cavity, JVAR, was 1.49 ml/min/1.73 m2 (SEM = +0.09, —0.08, N =
97), calculated as the geometric mean due to the skew distribution
(Fig. 5). The range was 0.13 to 3.77 ml/min/1.73 m2. Note that this
represents the reabsorption rate when there is no crystalloid
osmotic pressure difference at all across the peritoneal membrane,
(Eq. 16).(3.) The fluid flux through the large pores, JvL, was 0.078
ml/min/1.73 m2 with an SEM of + 0.005, —0.005, N = 97, calculated
as the geometric mean due to the skew distribution. The range
was 0.008 to 0.284 mi/mm/i .73 m2. Figure 6 gives the distribution
profile for JVL.
Other calculated parameters
The calculated capillary hydrostatic pressure, P , was constant
at 15 mm Hg in 89 patients. In 7 patients, the P was automatically
elevated 5 to 17 mm Hg since the lymph flows must exceed zero.
Area % of
Area parameter, the normal
A(/&, cm values in the
per 1.73 m2 adult population PET
> 30,000 > 127 High transport
23,600 —30,000 100—127 High average transport
17,200—23,600 73—100 Low average transport
<17,200 <73 Low transport
The hydraulic conductance, LS, was strictly coupled to the
A0/Ax in roughly one half of the patients. However, the LS could
be reduced to only 40% or raised to 250% of the value expected
from AW.X if an uncoupling was needed to adequately describe
the 'UF volume' (Eq. 7). The average LS was 0.069 0.03
mi/mm Hg/min/1.73 m2. Several of the patients with low LS
compared to the area parameter had problems with overhydration
and were identified as certain or potential "UF loss" patients.
The theoretical lymph flow calculated in the analysis was 0.41
ml/minhl.73 m2 BSA (geometrical mean), with an SEM of 0.06 and
a range of 0.00 to 2.21.
Reproducibility of PDC
In 15 patients it was possible to repeat the determinations
within a few days. Figure 7 shows the area parameters from the
first PDC measurement against the second, third and fourth
registrations. Standard deviations were calculated for each indi-
vidual patient. The coefficient of variation (CV% = sD/mean)was
used as a measure of the variability. The A0/zx had a coefficient of
variation of 7% with an SEM of 1%; for JVAR the CV% was 16%
with an SEM of 3% and for JvL CV% was 20% with an SEM = 4%,
N 15. The AJx showed little variation from time to time, while
JVL, reflecting protein loss, was less stable as previously noted [33].
PDC during peritonitis
The PDC test was performed in 11 patients with acute perito-
nitis. Nine patients were infected by Staphylococci (aureus or
coagulase negative) and one patient had a fungal peritonitis
(Candida Albicans). All parameters were higher in the group with
>0C
a)
a)
LL
40
30
20
10
I.'
Table 3. Area parameter conversion to PET
0 10
20
10
>0c
G)0
a)
U-
rnr in
0 1.2 2.4 3.6 4.8
Absorption, JVAR mi/mini1.73 in2
Fig. 5. The final reabsoiption rate of fluid from the abdominal cavity to
blood when there is no crystalloid osmotic pressure gradient left, N = 97.
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Large pore flow, JVL ml/min/1.73 m2
Fig. 6. The large pore fluid flux, Jv1, in the PD population of 97 patients.
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0 2000 4000 6000
Fig. 7. The reproducibility of the area parameter is shown by repeated
determinations of PDC within a week in the same patient (N = 15). The
second (•, N = 15), the third (0, N = 7) and the fourth (, N I PDC
measurements are plotted against the first. The coefficient of variation for
the area parameter is 7% in these 15 patients (± 1%).
peritonitis compared to control (Fig. 8). In the early phase of
peritonitis A0/zx was 48,650 cm/1.73 m2 (geometric mean, SEM =
+3370, —3150, range 31,200 to 68,600, N 11), JVAR was 1.78
ml/min/1.73 m2 (range 0.91 to 3.64, SEM = +0.27, —0.24) and Jv1
was 0.19 ml/min/I.73 m2 (range 0.06 to 0.43, SEM = +0.04, —0.03,
N = ii). In 6 patients PDC had been measured within a six month
period prior to the infection. In these patients the peritonitis
induced an 81% increase in the area parameter (range 40 to
120%). Two months after the peritonitis, the area returned to
previous values or less. In the patient with fungal peritonitis, the
area parameter was extremely small two months after the perito-
nitis, only 8087 cm/I .73 m2. He had been treated with HD and
could not return to PD.
Discussion
This project started with the idea of developing a method of
estimating the true PD capacities of individual patients based on
current theories of transcapillary exchange. Furthermore, a
straightforward experimental protocol should allow the patients
to collect the data themselves to mimic the normal PD day. The
study is not aimed to validate the three-pore model, but is a
pragmatic attempt to make clinical use of basic physiological
transport equations. Naturally, the success of such a venture
depends on the validity of the underlying mathematical model, as
well as the design of the protocol.
The three-pore model
Albeit somewhat simplistic, the three-pore model [19, 28] is
probably the best description of the peritoneal membrane to date
[34]. One of its major merits is that it seems to be universal for the
microvasculature of all organs [25, 32, 35]. Solutes are restricted
depending on their molecular size, whereas possible electrical
charge interactions are not accounted for in the present analysis.
This is mainly due to the ambiguity of data for the peritoneum, cf.
[36, 37]. Moreover, the pore dimensions were considered to be
constant in all patients, which is most likely close to reality, cf.
[25]. The area parameter, AJx, was 23,600 cm/1.73 m2 BSA and
for the studied adult population is a value similar to those
previously reported [281. In the present model, the capillary and
i.p. hydrostatic pressures were kept constant in all patients, except
in seven (7%) where the CapiJI was automatically raised to give
lymph flows above zero. However, Capi11 is most likely reduced if
the patient is hypotensive (for example dehydrated) and increased
in case of overhydration. Such alterations ii 1capi)l are not
accounted for in the present analysis, nor are changes due to body
position or alterations in the i.p. pressure. In the literature, there
are studies that could allow P1, to change with the intra-abdom-
inal volume [38]. The diffusion of sodium is less than expected
from the three-pore model, cf. [30]. Finally, there may be
interstitial concentration gradients or barriers [34, 39] reducing
the PS of glucose. It should be emphasized, however, that the
model works with remarkable precision for the vast majority of
solutes as well as for fluid transport. As an illustration of the
potentials of the present model, Figure 9 shows the predicted
effects of various osmotic agents on the drain volume plotted
against time for a patient with normal PDC pavamewrs. The
simulated effects are close to the values publishedin the.llturature
[40].
25
20
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>
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Fig. 8. Effects of peritonitis on the three PDC parameters. In accordance
with inflammatory reactions in other vascular beds, there are signs of
vasodilation, capillary recruitment, opening of large pores giving high
protein losses, mean SEM, N = 11.
Area' "Absorption' 'LargePoreFlow'
9e
"Area" for PDC #1, A0/1,, cm/1.73 m2
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Eli. . The osmotic effects of different Osmotic agents are simulated for a
patient with an average area = 24,100, slightly high JVAR = 1.6, JVL = 0.14
and L4.S 0.067. Theosmotic agents are: (solid curves) glucose 15, 25 and
40 glItter; (solid curve with filled circles) amino acid solution 10 g/liter;(hatched curve) small peptides 40 glliter, molecular wt = 800, SE radius =
0.64 nm; (open circles) glucose-polymer 75 g/liter + glucose 3.5 g/liter,
molecular wt = 18700, SE radius 2.10 nm. The osmotic agents are all
assumed to have a reduced PS analogous to i.p. glucose (Eq. 6).
How to interpret the PDC parameters
What is the morphological counterpart to the physiological
expression AjAx or the area parameter? The area represents the
unrestricted area (A0) of the pores in all capillaries perfused at a
given time normalized with respect to the diffusion distance (z.x).
The functional term 'pore' is probably equivalent to the interen-
dothelial junction at the microscopical level [41] and shows little
variation in its size or number. In most other organs, and most
likely the peritoneum, there is heterogeneity of perfusion, with
interrupted flow in some capillaries and high flows in others
changing with time [42], with only one out of four to six of the
capillaries being adequately perfused at any given time, ci. [431.
Hence, a large capillary reserve exists whereby the area parameter
can be increased several-fold, for example, during an inflamma-
tory reaction. Moreover, drugs and other conditions that affect the
recruitment of capillaries may affect the area parameter. Such
conditions include over/underhydration with subsequent involve-
ment of the sympathetic nerves, as well as certain vasodilators
[44) The instillation of acidic, lactate-containing hyperosmolar
solutions may also induce (short-lasting) recruitment of capillaries
and hence increase th area parameter.
The second PDC parameter, Jv, represents the sum of the
lymphatic flow and the transcapillary Starling forces (Eq. 16). The
latter also include the hydraulic conductance, LS, which is
calculated from the area parameter for most patients. The LS
can be uncoupled from A0IAx if needed to get an acceptable
description of the UF volumes (Eq. 7). Note that JvAR per se is
not dependent on any assumption of the underlying transport
route. The JVAR only reflects the last part of the drain volume
versus time curve. High rates of Jv were seen in the patients
with large area parameters, due to a more rapid dissipation of
glucose, but could also be seen in patients with a normal area
parameters.
The large pore fluid flux (JvL) determines the loss of proteins
from blood to the abdominal cavity. It is almost pure plasma that
flows through the large pore system with size discrimination for
the larger proteins only. The JVL is dependent on the hydrostatic
pressure gradient and the LS is accounted for by the large pores
(Eq. 13). There is no strict coupling of LS since an increase in
LS will be counterbalanced by an apparent reduction in the
number of large pores. An increased number of large pores
represents a true increase in the (capillary) permeability since it
affects the selectivity of the (PD) membrane. Indeed, inflamma-
tory reactions increase the number of large pores.
Comparison between the area parameter and PET
Most PD clinics are familiar with the PET terminology, where
the patient population is divided into four groups: high, high-
average, low and low-average transporters. The PET classification
is not corrected for the influence of the UF rate, but for most of
the cases it is possible to express the PETs in terms of the area
parameter according to Table 3. The term 'permeability' is
sometimes used to interpret PET instead of 'transporters,' but it is
not adequate in this situation, since 'high permeability' implies
altered membrane selectivity which has not occurred. It is there-
fore recommended that the use of (high/low) permeability should
be avoided.
Inflammatoty reactions
The typical inflammatory reaction is characterized by vasodila-
tation, capillary recruitment, opening of large pores (or 'leaks')
with a higher protein loss, increased lymph flow and pain. The
reactions observed in the acute phase of peritonitis are in
accordance with such an inflammatory reaction (Fig. 8). In some
patients the inflammatory reaction was rather weak, while in
others there were marked changes.
Nutritional aspects
As is shown in Table 2, the computer calculates the amounts of
calories and protein required for the particular patient during
almost resting conditions (Eq. 24). Moreover, the PD uptake of
calories with a given regimen is calculated together with the
estimated loss of proteins. The urea and creatinine generation
rates (UGR, CGR) are those obtained on the day of measure-
ment and are valid if that was a representative day, that is, normal
food intake, no infection, etc. This also applies to the protein
equivalent of nitrogen appearance rate, PNA [45] (previously
denoted protein catabolic rate, PCR), and to the estimation of
lean body mass, LBM. The PNA is calculated from UGR and
from the losses of protein in urine and PD fluid (Eq. 21). Note
that falsely high values of LBM can be obtained if the food
contains a significant amount of creatinine (that is, meat), an error
that has been calculated to be small [46] but probably significant
(Note added in proof).
Adequacy of dialysis
The calculated PD membrane characteristics can be used to
simulate any PD treatment. The results are presented as easily
understandable graphs showing the estimated values for clearance
(PD alone and PD + renal), the resulting removal of fluid (PD
and PD + renal) and the nutritional consequences (see above).
An example of the results in terms of clearance and 'UF-volume'
is shown in Figure 10. The clearance of the renal replacement
therapy is calculated for a solute the size of creatinine and is
suggested to be at least 5.5 ml/min/1.73 m2, corresponding to a
weekly creatinine clearance (PD + GFR, not PD + renal
creatinine clearance) of 55 liters [13]. There is considerable
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experience of measuring the glomerular filtration rate of nondi-
alysis patients with renal insufficiency [471, and many centers
recommend that dialysis should be started at a renal residual
function (RRF) of 5 ml/min or more to prevent the loss of
important body functions [48]. It therefore seems logical to
ascertain that the dialysis clearance reaches the minimal level of
5.5 mI/mm at least for creatinine, since the clearance of larger
solutes will be lower with PD than the renal clearance (higher
values will be seen for urea). The computer can easily calculate
the predicted clearance of any solute based on its molecular size
and several other solutes are presented on the screen on demand.
The resulting Kt/V value for urea is also calculated, using V =
58% of the body weight.
Pedagogical aspects
A subjective experience of PDC is that both physicians and
nurses have gained insight into the physiological properties of the
PD membrane and how PD works. Several patients have also
taken an active part in the interpretation of the PDC results,
giving an improved patient motivation, knowledge and compli-
ance although these effects have not been quantified. The issue of
patient compliance is often neglected. However, recent studies
have suggested that almost one fourth of the patients use a lower
dose of dialysis than prescribed, and the total dialysis dose is
approximately three fourths of that expected [49, 50]. Therefore,
it is essential to optimize the patient motivation and hence patient
compliance in order to ensure adequate dialysis. The PDC
program seems to be useful in this respect as well.
Urea kinetic modeling
There have been attempts to use urea kinetic modeling based
on the Pyle, Moncrief and Popovich model [51] as a prescription
aid in PD [11]. This widely used model has important drawbacks:
(i) The membrane is considered to be extremely permeable to
small solutes, allowing almost free diffusion. (ii) On the other
hand, the membrane is highly selective with respect to osmosis,
showing high 'apparent' reflection coefficients for small solutes,
for example, 0.5 for glucose. Note that these two properties are
incompatible. (iii) Using current irreversible thermodynamics to
calculate pore radii [52], the apparent pore radius in that model
seems to increase with increasing solute size. (iv) Finally, larger
solutes are not more effective osmotic agents than glucose accord-
ing to the model [53], but actual measurements show that they are
more effective [54]. In contrast, the three-pore model gives
predictions close to those observed in vivo (Fig. 9). Naturally,
there are limitations with the present three-pore model, but it is
internally more consistent and offers a universal description of the
fluxes of fluids and solutes across microvasculature in almost all
organs [26]. More studies are required, however, to improve the
analysis further. Hopefully, the PDC method can stimulate such
efforts and be used to better quantify the effects of various drugs,
osmotic agents, etc.
Economical aspects
The nursing time required for PDC include giving adequate
instructions, handing over a standardized PDC kit, taking two
blood samples, sending the samples to the laboratory and entering
the data into the computer. The patients perform the PDC test
themselves, which makes the nursing time less than with tradi-
tional PET. A total of six PD samples (5 during the PDC day +
the start sample), one urine sample and two blood samples are
collected. The cost of the chemical analyses varies between
laboratories and therefore it seems suitable to make a relative
comparison. Thus, in Goteborg the cost of the PDC test is less
than half of a renal clearance measurement (Cr-EDTA), 10%
more than the cost of PD fluids during one day, 50% more than
the cost of a chest X-ray, or about the same as one injection of
erythropoetin (5400 units).
Conclusion
Basic physiology can be utilized for the description of the PD
exchange in individual patients. The patient can perform the PDC
measurements himself during an almost normal CAPD day thus
requiring a minimum of nursing time. The resulting peritoneal
dialysis capacities are reproducible and can be used to ascertain
adequate dialysis and to predict the effects of any dialysis treat-
ment. Hence, PDC seems to be useful in the management of the
PD patients. Moreover, the dramatic microvascular changes in-
duced by peritonitis are in total agreement with the inflammatory
reaction observed in other vascular beds. With a tool that
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Fig. 10. The results in terms of clearance for a
solute the size of creatinine A and fluid removal
B are presented graphically. RRF is residual
renal function. The hatched line represents the
minimal clearance level of 5.5 ml/min/1.73 m2
BSA.
Haraidsson: Individual PD capacity 1195
interprets the intricate processes of PD in physiologically appro-
priate parameters, there may not be a need for guessing or using
semiquantitative tests.
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Appendix
List of abbreviations
The terminology is based on the recommendations of the International
Physiological Society [56].
Weight (kg)
Height (m)
The body surface area (in m2)
Capillary hydrostatic pressure (15 mm Hg)
Intraperitoneal hydrostatic pressure (6 mm Hg)
Osmotic pressure (mm Hg) where the subscript
denotes protein (prot), glucose (gluc), urea, sodium
(Na) or anions
Stokes-Einstein radius (nm)
Pore radius (nm)
The ratio of solute to pore radii (ae/rp)
Small pore radius (4.7 nm)
Large pore radius (25.0 nm)
Residual volume (ml)
Volume of the dialysis fluid prior to instillation
Concentrations in plasma and dialysate
Clearance (in ml/min/1.73 m2 BSA)
The universal gas constant
The absolute temperature
Avogadro's number
The viscosity of water
The hydraulic conductance or the UF coefficient
(ml/min/mm Hg/1.73 m2 BSA)
Unrestricted pore area over diffusion distance (the
area PDC parameter, cm/I .73 m2 BSA)
Am/AO The fractional area available for diffusion of a solute
m
The reflection coefficient for a solute m
The free diffusion coefficient for a solute m (cm2/s)
Fluid flux (ml/min)
The final reabsorption rate of fluid from the abdom-
inal cavity to blood ("absorption", ml/min/1.73 m2
BSA)
Large pore fluid flux ("large pore flow," ml/min/1.73
m2)
Lymph flow (ml/min/1.73 m2)
The flux of solute (mmol/min or g/min)
Urea generation rate (mmol/day)
PNA Protein equivalent of nitrogen appearance rate (g/
Subscripts:
kg/day)
Creatinine generation rate (mmol/day)
Lean body mass (kg)
c,s,L the cell, small or large pore pathway
m a solute m
Basic capillary exchange parameters
There are several estimations of the body surface area from a
person's height (L, in m) and weight (W, in kg) including the one
below [57]:
BSA = 0.02350 (100 L)°4 (Jq 1)
The body mass index (BMI in kg/rn2) is given by:
W
BM1= (Eq.2)
The free diffusion coefficient is related to the Stokes Einstein
radius of a solute:
R T 327656 10
D37'= = (Eq.3)67r'ii'N'ae ae
In the literature there are several equations describing the
fractional pore area available for diffusion of a solute rn, but the
expression covering most solute sizes was presented by Mason,
Wendt and Bresier [52]:
=
(1 — a)9112
A0 1—0.3956' a+1.0616 q.4)
and for calculations of the solute reflection coefficient [52]:
(1_a)2. [2_(1_a)2]. (i_l
3)
a2a2
1——+-— (Eq.5)33
where a is the ratio of the solute m Stokes Einstein radius over the
pore radius.
The diffusion capacity, or permeability surface area (PS), of a
solute m is given by:
P'Dm (Eq.6)
Urea is, however, more soluble in oil than are, for example,
glucose and creatinine, as reflected by a three- to fivefold higher
octanol/water partition coefficient [58]. As a result the PSurea is
increased by a factor of 1.2, allowing for some transport through
the lipid membranes. On the other hand, the PSgiucose is less than
predicted from the A0/& [28], which may be due to properties in
the interstitiurn, such as interstitial concentration gradients or
interstitial restriction of diffusion, serial barriers, etc. [34]. There-
fore SgjucoSe was reduced by a factor of 0.8. Moreover, the PS for
sodium is only 6 ml/min/1.73 m2 [30], while PS for most other
hydrophilic solutes seem to be well predicted from equation 6.
Initially, there seem to be a vasodilatation and recruitment of
CGR
LBM
W
L
BSA
'capi1l
Pip
subsript
rp
a
re,,
rPL
VReS
VDF
C, C
Cl or K
R
T
N
LS
Dm
JvJv
JVL
"Lympl,
Js
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capillaries that transiently increased PS of allsolutes with a factor known, using the following non-linear fluxequation. Thus, clear-
of 1 + e004, t is in minutes. ance of a solute m through the small pores is:
The hydraulic conductance L S or the
normally close to 0.070 mI/mm/mm Hg/1.73
LS was calculated from the A,Jzx as:
UF coefficient is
m2 [281. Therefore, Jv (1 — cr ) 1 — -e-PeS sm c
1— e_'e (Eq. 14)
0.070•
where the modified Peclet number is:IS= 23000 (Eq. 7) JVs (1 — °s,m)Pe = (Eq. 15)No more than a 5% deviation of "UF volume" is accepted, PSs,m
otherwise there is uncoupling of LS from the A0/.x. This
deviation is calculated as (VUF/VDF), where ZWUF is the differ- The concentration ratio (CD/CP) in equation 14 is inverted if the
ence between measured and calculated UF volume and VDF the concentration in the dialysate exceeds that of plasma, which
infused volume of dialysis fluid. Plasma proteins exert a colloid normally is the case solely for glucose. Similar calculations are
osmotic pressure which can be calculated [21] as: made for the clearance of solutes through the large pores. The
total clearance is merely the sum of the small and the large pore
= 2.1 + 0i6(S 2 irot3 (Eq. 8) clearances.) + 0 The final reabsorption rate of fluid from the abdominal cavi
occurs when the crystalloid osmotic gradients have dissipated and
where Cprot is the total protein concentration in glliter. Several is thus given by:
laboratories do not analyze total protein in serum (Sprot) and
approximate Sprøt concentrations can be calculated from mea- Jv1 = — LpS[Pcapiii — I)jp — oprot(1Tp — )J+ Jvh (Eq. 16)
sured Saib values: Cprot = Caib/O.4783, based on 78 patients. The Note that lymph flow is only one (minor) component of JVAR.
ratio of the two calculated osmotic pressures (prot/alb) is 1.000
0.0195 (N = 78).
Each solute exerts a crystalloid osmotic pressure (in mm Hg) Changes of intraperitoneal volume and solute concentrations
according to van't Hoffs law: with time
= R T 19.33 • (Eq 9) The following equations are used to estimate the initial solute
concentration i.p. at the start of the PD cycle:
where C is given in mmol/liter.
According to the three-pore concept, the reflection coefficient VDF CDF + VRe5 CRes
for the membrane as a whole is the result of the characteristics of CD(O) = (Eq. 17)VDF + VReS
three independent pore populations. Thus, the weighted average
reflection coefficient for solute m (o-,) is:
LpS LS5 LpSL
= 0c,m + + I,m (Eq. 10)
tot LS505 LpS0
where LS505 is the hydraulic conductance of the entire mem-
brane.
The fluid flux through the cell pathway is:
Jv LpS (Pcapiii — lTprot — gluc — urea — Na — iranions)
where LS is 1.0% of total hydraulic conductance (LS0) of the
membrane.
The fluid flux through the small pores are given by:
resetjv5 = LpS (Pcapiii — sprot — Pip — OsgJuc — 0surea — sWa (Eq. 18)
Finally, the fluid flux through the large pores is:
where CDF stands for the concentration of solutes in the dialysis
fluid prior to instillation. The residual volume is scaled to the body
weight as: VReS -- that is, 250 ml for a 70 kg human. CRe5
is the concentration in the residual volume, which is unknown at
the start of the PDC protocol but thereafter is given by the
previously drained fluid. As reasonable estimates of CRCS at the
start of the protocol the following expression was used: CRCS =
k C; where k is 1 for glucose and sodium, k is 0.8 for urea and
creatinine and k is 0.05 for albumin. Note that this approximation
is needed only for the start of the PDC protocol, not the
(Eq. 11) subsequent 4 or 5 exchanges.Numerical integration was used to obtain the changes of
volume and concentration with time, using two minute steps for
the first hour followed by steps of 10 minutes. Thus, the i.p.
volume after a short time interval is:
— osirions)
V(t + t) = V(t) + zt (Jv + Jv5 + JVL — JVLPh)
(Eq. 12) The concentration of a solute m after a short time interval is:
JVL = LPSL (Peapiti — P1) (Eq. 13)
CD,m(t) V(t) + (s + L),m t Cp,m(t)
CD,m(t + t) = (Eq.19)V(t + zt)
since no significant osmotic gradients can be maintained across The residual renal function (RRF) can be estimated from the
these pores. mean of the clearances of urea and creatinine with reasonable
The transport of
easily obtained once
different solutes across the membrane are
the partial fluid fluxes through the pores are
accuracy if RRF is less than 15 ml/min [471. The clearance for
urea or creatinine (in mI/mm/I .73 m2 BSA) is given by:
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a c1j Vj 1.73 Note added in proofCp 24 60 BSA Creatinine kinetics cannot be used due to variabilities in meat intake.
HARALDSSON B, JoHANssoN A-C, Armw'l P-O: Creatmine generation
rate—A blunt tool for assessments of lean body mass, (abstract) JAm Soc
Nephrol 5:492, 1994
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